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Abstract The severely obese patient has varying degrees of intrinsic reduction of expiratory flowrates and lung vo-
lumes.Thus, the severely obese patient is predisposed to postoperative atelectasis, ineffective clearing of respiratory
secretions, and other pulmonary complications.This study evaluated the effect of bi-level positive airway pressure (Bi-
PAP) on pulmonary function in obese patients following open gastric bypass surgery. Patients with a body mass index
(BMI) of at least 40 kg/m2 whowere undergoingelective gastric bypasswere eligible to be randomized to receive either
BiPAP during the first 24 h postoperatively or conventional postoperative care.Patients with significant cardiovascular
and pulmonary diseases were excluded from the study. Forced vital capacity (FVC), forced expiratory volume in 1s
(FEV1.0), peakexpiratory flowrate (PEFR), andpercenthemoglobinoxygen saturation (SpO2) weremeasuredpreopera-
tively, and on postoperative days1, 2, and 3.Twenty-seven patients were entered in the study,14 received BiPAP and13
received conventional postoperative care.There was no significant difference preoperatively between the study and
controlgroups inregards to age,BMI,FVC,FEV1.0.PEFRor SpO2.Postoperatively, expiratory flowwas decreased inboth
groups.However, the FVCand FEV1.0 were significantlyhigheroneachofthethree consecutivepostoperative daysinthe
patients who received BiPAP therapy.The SpO2 was significantly decreased in the control group over the same time
period.Prophylactic BiPAP during the first12--24 h postoperatively resulted in significantly highermeasures of pulmon-
ary function in severelyobese patientswho hadundergone elective gastric bypass surgery.These improvedmeasures of
pulmonary function, however, didnottranslateinto fewerhospitaldaysor a lowercomplicationrate inour studypopula-
tion of otherwise healthy obese patients. Further study is necessary to determine if BiPAP therapy in the first 24 post-
operative hours would be of benefit in severely obese patients with comorbid illnesses who have undergone elective
gastric bypass.r2002 Elsevier Science Ltd.Allrights reserved.
doi:10.1053/rmed.2002.1357, available online athttp://www.idealibrary.comon
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The function of respiratory muscles and diaphragmatic
excursion are impaired in the severely obese (1).There is
also restriction of the ability of the chestwall to expand.
Thus, vital capacity, total lung capacity, functional resi-
dual capacity, forced expiratory volume in 1s (FEV1.0),
and expiratory reserve volume are all reduced. These
parameters are usually normal in those with mild-to-
moderate obesity (1,2).The severely obese patients whoReceived18 September 2001, accepted in revised form1April 2002.
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Fax: 423 979 3471; E-mail: vicel520@yahoo.comundergo upper abdominal surgery have greater post-
operative risk of developing pulmonary complications
due to these limitations of pulmonary function (3,4).
Bi-level positive airway pressure (BiPAP) systems
combine pressure support ventilation (PSV) with posi-
tive end expiratory pressure (PEEP). The di¡erent in-
spiratory and expiratory positive airway pressures are
delivered to the patient via nasal or face mask. BiPAP
has been used successfully to treat respiratory failure of
various etiologies including obstructive sleep apnea,
chronic obstructive lung diseases, and pulmonary edema
(5^11). BiPAP may allow for alveolar recruitment during
inspiration and prevent expiratory alveolar collapse and
may thereby decrease postoperative complications from















FIG. 1. Patient’s randomization.
BI-LEVELPOSITIVE AIRWAYPRESSUREEFFECT 673obesity (12).This studyevaluated the impactof prophylac-
tic use of BiPAP on measures of pulmonary function in
severely obese patient following gastric bypass surgery.
MATERIALSANDMETHODS
The study was conducted in a suburban community hos-
pital between August1999 andMay 2000.The local Insti-
tutional ReviewBoard approved this study.Twenty-seven
consecutivepatientsreferredby their primaryphysicians
for gastric bypass surgery were recruited to participate
in the study. All of the patients were obese with a body
mass index (BMI) of more than 40kg/m2. Each patient
had failed to lose weight by dietary and medical treat-
ment. All thepatientsunderwentopenRoux-enYgastric
bypass surgery performedby the same surgeon.
Patients with signi¢cant cardiovascular diseases,
chronic obstructive lung diseases, obstructive sleep ap-
nea, and obesity hypoventilation syndrome were ex-
cluded from the study. Patients who required
mechanical ventilation formore than 6hpostoperatively,
had complicated surgery, or were unable to tolerate the
BiPAP system for at least12hwere also excluded.
Randomization of the patients to the study or control
group was accomplished by selecting the next sequen-
tially numbered sealedenvelope that contained a compu-
ter-generated assignment. Fourteen patients were
assigned to BiPAP group and 13 patients to the conven-
tional treatment group (Fig.1).The study group received
BiPAP (Knightstarr 335, Nellcor Puritan Bennett Inc.,
4280 Hacienda Drive, Pleasanton, CA) with an inspira-
tory positive airway pressure (IPAP) of12 cmH2O and an
expiratory positive airway pressure (EPAP) of 4 cmH2O.
BiPAPwas continued for at least 2 h out of every 3h dur-
ing the ¢rst12^24hpostoperatively.The BiPAPmachines
were set and the nasal masks (Nellcor Puritan Bennett
Inc., 4280 Hacienda Drive, Pleasanton, CA) ¢tted by
trainedrespiratory therapists.During the1h rest period
the study patients were placed on 5 l/min of oxygen via
nasal canula.Oxygen, 5 l/min, was delivered to the con-
trol patients by nasal canula immediately after extuba-
tion following surgery.
Both groups were monitored for postoperative com-
plications. The study group was also evaluated for facial
skin abrasions and breakdown from the nasal mask.The
patients’ anesthesia induction, general anesthesia, and
patient controlled anesthesia were reviewed. The dura-
tion of hospital stay and the use of incentive spirometry
were also investigated.
Forced vital capacity (FVC), FEV1.0, and peak expira-
tory £ow (PEFR) were measured at the same time of
dayduring the ¢rst, second, and thirdpostoperativedays
using the PB-100 portable spirometer (Nellcor Puritan
Bennett Inc., 4280HaciendaDrive, Pleasanton,CA)with
the patient in a sitting position. The best of threematched attempts was recorded. Oxygen saturation
(SpO2) at room air wasmeasuredusing the pulse oxime-
try (N-3000,Nellcor Puritan Bennett Inc., 4280 Hacien-
da Drive, Pleasanton,CA) with the patient sitting.
Datawere reported asmean7 SD and analyzedusing
an unpaired t-test with Welch correction. Pearson chi-
square analysis compared the frequency di¡erences be-
tween the two groups. Results were considered signi¢-
cant if Po0.05.
RESULTS
Six of the 27 patients enrolled subsequently were with-
drawn from the study. Five patients in BiPAP groupwere
removed; four patients were unable to tolerate BiPAP
and one had a surgical complication that required pro-
longed postoperative mechanical ventilation. The main
reasons for not completing at least12h of postoperative
BiPAP therapy were discomfort caused by the positive
airway pressure and the nasal appliance and an inability
to sleepwith the device in place.Out of nine patients re-
maining in the studygroup, two patients completed 24h,
two patients completed 16^23h, and ¢ve patients com-
pleted12^15h of BiPAP therapy.One patient in the con-
trol group requiredprolongedpostoperativemechanical
ventilation and was omitted from the data analysis
(Fig.1).
Comparison of the study and control patients’ demo-
graphic characteristics, preoperative pulmonary func-
tion tests (FVC, FEV1.0, and PEFR), and preoperative
SpO2 revealed no signi¢cant di¡erences between the
two groups (Table 1). The parameters of pulmonary
function (FVC, FEV1.0, and PEFR) and SpO2 of both
groups deteriorated signi¢cantly postoperatively. On
postoperative day 1, FVC had decreased to 44% from
baseline in control group compared to 55% with BiPAP
group (Fig. 2). Similarly, on the ¢rst operative day the
FEV1.0 dropped to 44% from their baseline in control
group and to 54% in the BiPAP group (Fig. 3). The FVC
and FEV1.0 were signi¢cantly higher in the study group
when compared to the control group (Po0.05). PEFR
was higher in the study group than the control group
TABLE 1. Patients’preoperative baseline characteristics
BIPAP (n=9) Control (n=12) P value
Age (year) 3776 35710 NS
Sex (M/F) 1/8 0/12 NS
BMI (kg/m2) 5077 4775 NS
Smoking 1/9 1/12 NS
FVC (l) 3.2270.83 3.3970.67 NS
FEV1 (l) 2.7370.64 2.7570.66 NS
PEFR (l/s) 5.6971.61 5.7371.02 NS
SpO2 (%) 96.970.9 97.870.8 NS
Values are mean7 SD.BMI (body mass index), FVC (force
vital capacity), FEV1 (force expiratory volume in 1s), PEFR
(peak expiratory £ow rate), SpO2 (pulse oximetry at room
air),NS (not statistically signi¢cant).
FIG. 2. Themeasured FVCon postoperative days (POD) 1^3
compared from their baseline preoperative FVC. Values are
mean7SD. *Po0.05.
FIG. 3. Themeasured FEV1on postoperative days (POD) 1^3
compared from their baseline preoperative FEV1. Values are
mean7SD. *Po0.05.
FIG. 4. Themeasured PEFRonpostoperative days (POD) 1^3
compared from their baseline preoperative FVC. Values are
mean7SD.NS (not statistically signi¢cant).
FIG. 5. Themeasured SpO2 onpostoperative days (POD) 1^3
compared from their baseline preoperative SpO2. Values are
mean7SD. *Po0.05.
674 RESPIRATORYMEDICINEbut did not reach statistical signi¢cance (Fig. 4).On post-
operative day 1, the mean SpO2 for the BiPAP and con-
trol groups were 97 and 94%, respectively (Fig. 5).These
higher levels and statistical signi¢cance in FVC, FEV1.0,
and SpO2 in the BiPAP group were sustained through
postoperative days 2 and 3 group (Po0.05). The PEFR,
although maintained at a higher level in the study group,
continued to have no statistical di¡erence between the
two groups on postoperative days 2 and 3.
Both groups had similar anesthesia, pain control, and
incentive spirometry regimens.The duration of hospitalstay was not signi¢cantly di¡erent between the two
groups of patients (BiPAP, 5.571.3 days; control,
5.271.8 days). The duration of hospitalization was dic-
tated by the recovery of bowel function and routine
postsurgical care.No cardio-pulmonary or other clinical
complication such as aspiration or abdominal distention
was observed in either group.Therewere no facial abra-
sions identi¢ed in the study group from to the nasal ap-
paratus. Since the BiPAP therapy was part of an
experimental protocol, the precise cost of this interven-
tion could not be determined.
DISCUSSION
The fall in expiratory reserve volume in obesity is due to
small-airway closure. Lung compliance is also reduced
secondary to low lung volumes and elevation of the
hemi-diaphragms especially during recumbency. Thus,
the obese patient is predisposed to atelectasis and inef-
fective clearing of mucus.Work of breathing in the se-
verely obese is increased because of abnormal chest
elasticity, increased chest wall resistance, increased air-
way resistance, abnormal diaphragmatic position, and
upper airway resistance (1,2).To help minimize the work
of breathing, obese individuals take more frequent but
BI-LEVELPOSITIVE AIRWAYPRESSUREEFFECT 675smaller volume breaths but their ability to increasemin-
ute ventilation is limited. Ventilation^perfusion mis-
match is common in the severely obese patient
especially in the supine position and may cause hypoxe-
mia (2).This hypoxemia may contribute to the increased
risk of sudden death observed in the severely obese.
Moreover, obese patients dedicate a disproportionately
high percentage of total oxygen consumption (VO2) and
carbondioxideproduction (VCO2) to conduct respiratory
work, even during quiet breathing (13).This relative inef-
¢ciency suggests a decreased ventilatory reserve and a
predisposition to respiratory failure in the setting of
evenmild pulmonary or systemic insults.
Obesity is a major cause of postoperative complica-
tions. Studies have found that after upper abdominal sur-
gery, obesity was one of themost important risk factor
associated with clinically signi¢cant atelectasis (14). Pul-
monary complications were more frequent, were asso-
ciated with longer hospital stay and occurred in
combination with cardiac complications in a substantial
proportion of cases (3).The severely obese have mortal-
ity rates two or three times as high as normal patients.
This is especially truewith long verticalupper abdominal
incisions (4).
This study demonstrates that the prophylactic use of
BiPAP during the ¢rst 12^24h following gastric bypass
surgery on severely obese patients signi¢cantly raises
measures of pulmonary function when these indicators
are compared to a control group. A 24^30% increase in
FVC and FEV1.0 relative to the control group resulted
from noninvasive ventilatory support. These improve-
ments were not as substantial when compared to a pre-
vious studyon a similar population (12).Thismightbe due
to the less time spent on the BiPAP system by our pa-
tients.The higher levels of FVC, FEV1.0, and SpO2 in the
study group were preserved even after discontinuation
of the noninvasive ventilation.These data aremost likely
explained by a decrease in pulmonary microatelectasis
and an increased functional residual capacity (FRC) due
to the application of positive airway pressure in the ¢rst
12^24h after surgery (15,16).Our data mirror previously
reported observations (12).
In agreementwith other publisheddata, BiPAP didnot
result in a signi¢cant improvement in PEFR in our pa-
tients (12). This ¢nding may in part be explained by the
fact that, although the FEV1.0 and the PEFR are similar
dynamic expiratorymaneuvers, the time course and the
magnitude of the changes in these two parameters are
not identical.
The optimalpressure for IPAP and EPAP following gas-
tric bypass surgery in the severely obese is not known. A
previous report suggests that an IPAP of 8 cm H2Omay
be inadequate in obese patients to prevent the post-
operative pulmonary restrictive syndrome. These
authors propose that 12 cm H2O of IPAP promotes lung
in£ation and 4cmH2O of EPAP prevents end-expiratoryalveolar collapse (12).These settings were well tolerated
and there was no increase in complication in their pa-
tients treated with these pressures. While our study
was not designed to investigate the optimal level of Bi-
PAP, our data con¢rm their observations that an IPAP of
12 cmH2Oand anEPAPof 4 cmH2Oresult inhigherpost-
operative measures of pulmonary function.The optimal
IPAP and EPAP, however, for any given patient are di⁄-
cult to predict and will require more research before
the clinician will be able to reliably forecast what pres-
sures to use.
Our patients did not tolerate BiPAP as well as pre-
viously reported accounts of postoperative BiPAP in se-
verely obese patients undergoing gastric bypass surgery
(12).Twenty-nine percent of our patients enrolled in the
study groupwithdrew due to an inability to tolerate this
treatment for at least12h.This is more than the intoler-
ance to this treatment reported previously in13% of pa-
tients (12).Thereason for this di¡erence is notclear but is
probably due to a number of factors including patient
education and expectations of BiPAP. Patient tolerance
of BiPAP and the nasal apparatus may be improved by a
preoperative education and a trial of BIPAP before sur-
gery.
Whether ornot the observede¡ects ofpostoperative
BiPAP on pulmonary function following gastric bypass
surgery are clinically relevant remains to be answered.
While there were signi¢cant di¡erences in the FVC,
FEV1.0, and SpO2 between our patients who did and did
not receive BiPAP, the duration of hospital stay for each
group was the same. The hospital stay, however, was
mainly dependent on the recovery of gastrointestinal
motility rather than pulmonary function.No cardio-pul-
monary or other complication was observed in either
group.This ismay be due to the relative health of the pa-
tients thatwere enrolled in our study.Whether inclusion
of a larger numberof patients into this study would even-
tually result in clinically signi¢cant ¢ndings in patient out-
come is debatable.The exact cost of BiPAP therapy was
notdetermined.However, due to the greater intensity of
postoperative care providedby respiratory care person-
nel, a higher cost of hospitalizationwould be expected if
this intervention was routinely employed following gas-
tric bypass surgery in the severely obese.
The limitations of our study were the number of sub-
jects and the exclusions of patients with cardio-pulmon-
ary and other comorbid illnesses who might clinically
bene¢t from postoperative BiPAP. Nevertheless, our
study demonstrates that the prophylactic use of BiPAP
with an IPAP of 12 cmH2O and EPAP of 4 cmH2O during
the ¢rst 12^24h following gastric bypass surgery signi¢-
cantly improved measures of pulmonary functions in
otherwise-healthy but severely obese patients. Since Bi-
PAP therapy has been employed e¡ectively to treat pul-
monary insu⁄ciency due to a variety of disease
processes, then patients with underlying comorbid
676 RESPIRATORYMEDICINEillnesses who are undergoing gastric bypass surgerymay
be the population that bene¢ts most from this therapy.
The improvement in pulmonary function from prophy-
lactic BiPAP observed in this study of otherwise-healthy
obese patients suggests that further research should be
performed to determine what advantage this interven-
tionmayhave for the severelyobesepatientswithunder-
lying comorbid conditions that are undergoing bariatric
surgery.
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